Emerging Endoscopic Imaging Technologies for Bladder Cancer Detection

  • Aristeo Lopez
  • Joseph C. LiaoEmail author
New Imaging Techniques (A Atala and A Rastinehad, Section Editors)
Part of the following topical collections:
  1. Topical Collection on New Imaging Techniques


Modern urologic endoscopy is the result of continuous innovations since the early nineteenth century. White-light cystoscopy is the primary strategy for identification, resection, and local staging of bladder cancer. While highly effective, white light cystoscopy has several well-recognized shortcomings. Recent advances in optical imaging technologies and device miniaturization hold the potential to improve bladder cancer diagnosis and resection. Photodynamic diagnosis and narrow band imaging are the first to enter the clinical arena. Confocal laser endomicroscopy, optical coherence tomography, Raman spectroscopy, UV autofluorescence, and others have shown promising clinical and pre-clinical feasibility. We review their mechanisms of action, highlight their respective advantages, and propose future directions.


Optical imaging Fluorescence imaging In vivo microscopy Multimodal imaging Cystoscopy Bladder cancer 



The authors thank Kathleen Mach for critical review of the manuscript. A.L. is supported by the Stanford University School of Medicine MedScholars Research Fellowship. J.C.L. is supported in part by grant R01 CA160986 from the National Cancer Institute.

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Aristeo Lopez declares no potential conflicts of interest relevant to this article.

Dr. Joseph C. Liao received a research grant from the National Institute of Health (NIH). Dr. Liao received travel support from Mauna Kea Technologies, including expenses covered or reimbursed, and payment for the development of educational presentations from Storz.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.•
    Herr H. Early history of endoscopic treatment of bladder tumors from Grunfeld ’ s Polypenkneipe to the Stern-McCarthy Resectoscope. J Endourol. 2006;20(2):85–91. This article highlights the most noteworthy innovations that occurred in urologic endoscopy providing an overview of the history of endoscopy and the endoscopic management of bladder tumors.PubMedCrossRefGoogle Scholar
  2. 2.
    Natalin RA, Landman J. Where next for the endoscope? Nat Rev Urol. 2009;6(11):622–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Samplaski MK, Jones JS. Two centuries of cystoscopy: the development of imaging, instrumentation and synergistic technologies. BJU Int. 2009;103(2):154–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Witjes JA. Bladder carcinoma in situ in 2003: state of the art. Eur Urol. 2004;45(2):142–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol. 2000;113(2):275–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Babjuk M. Transurethral resection of non–muscle-invasive bladder cancer. Eur Urol Suppl. 2009;8(7):542–8.CrossRefGoogle Scholar
  7. 7.
    Liu J-J, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: considerations and perspectives. J Urol. 2012;188(2):361–8.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57(4):595–606.PubMedCrossRefGoogle Scholar
  9. 9.
    Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer. Can J Urol. 2012;19(2):6227–31.PubMedGoogle Scholar
  10. 10.
    Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, et al. A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc. 2012;26(12):3634–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Rink M, Babjuk M, Catto JWF, Jichlinski P, Shariat SF, Stenzl A, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol. 2013;64(4):624–38.PubMedCrossRefGoogle Scholar
  12. 12.
    Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012;188(1):58–62.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Cauberg ECC, Kloen S, Visser M, de la Rosette JJMCH, Babjuk M, Soukup V, et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology. 2010;76(3):658–63.PubMedCrossRefGoogle Scholar
  14. 14.
    Naselli A, Introini C, Bertolotto F, Spina B, Puppo P. Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging. J Endourol Endourol Soc. 2010;24(7):1131–4.CrossRefGoogle Scholar
  15. 15.
    Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol. 2012;61(5):908–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Naito S, van Rees Vellinga S, de la Rosette J. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. J Endourol Endourol Soc. 2013;27(1):1–3.CrossRefGoogle Scholar
  17. 17.
    Sonn GA, Jones S-NE, Tarin TV, Du CB, Mach KE, Jensen KC, et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182(4):1299–305.PubMedCrossRefGoogle Scholar
  18. 18.•
    Wu K, Liu J-J, Adams W, Sonn GA, Mach KE, Pan Y, et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology. 2011;78(1):225–31. This article compiled representative confocal images from the urinary tract into an imaging atlas. The atlas was used to develop the diagnostic imaging criteria for benign and neoplastic conditions of the urinary tract to facilitate the use and enable adaptation of CLE.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Chang TC, Liu J-J, Hsiao ST, Pan Y, Mach KE, Leppert JT, et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol Endourol Soc. 2013;27(5):598–603.CrossRefGoogle Scholar
  20. 20.
    Wallace MB, Meining A, Canto MI, Fockens P, Miehlke S, Roesch T, et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 2010;31(5):548–52.PubMedCrossRefGoogle Scholar
  21. 21.
    Adams W, Wu K, Liu J-J, Hsiao STT, Jensen KC, Liao JC. Comparison of 2.6- and 1.4-mm imaging probes for confocal laser endomicroscopy of the urinary tract. J Endourol Endourol Soc. 2011;25(6):917–21.CrossRefGoogle Scholar
  22. 22.•
    Hsiung P-L, Hsiung P-L, Hardy J, Friedland S, Soetikno R, Du CB, et al. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med. 2008;14(4):454–8. This study identified and synthesized a peptide, VRPMPLQ, that bound more strongly to dysplastic colonocytes than to normal cells. By conjugating the peptide to fluorescein the fluorescent signals were detected with CLE.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Sturm MB, Joshi BP, Lu S, Piraka C, Khondee S, Elmunzer BJ, et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med. 2013;5(184):184ra61.PubMedCrossRefGoogle Scholar
  24. 24.
    Hermes B, Spöler F, Naami A, Bornemann J, Först M, Grosse J, et al. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology. 2008;72(3):677–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Goh AC, Tresser NJ, Shen SS, Lerner SP. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology. 2008;72(1):133–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Willmann E. Optical coherence tomography for bladder cancer-ready as a surrogate for optical biopsy? -Results of a prospective mono-centre study. pp. 131–4; 2010.Google Scholar
  27. 27.
    Lingley-Papadopoulos CA, Loew MH, Manyak MJ, Zara JM. Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis. J Biomed Opt. 2013;13(2):024003.CrossRefGoogle Scholar
  28. 28.
    Bus MTJ, Muller BG, de Bruin DM, Faber DJ, Kamphuis GM, van Leeuwen TG, et al. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study. J Urol. 2013;190(6):2236–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Bonnal J-L, Rock A, Gagnat A, Papadopoulos S, Filoche B, Mauroy B. Confocal laser endomicroscopy of bladder tumors associated with photodynamic diagnosis: an ex vivo pilot study. Urology. 2012;80(5):1162.e1–5.CrossRefGoogle Scholar
  30. 30.
    Chang TC, Liu J-J, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp. 2013;(71):e4409.Google Scholar
  31. 31.
    Schmidbauer J, Remzi M, Klatte T, Waldert M, Mauermann J, Susani M, et al. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder. Eur Urol. 2009;56(6):914–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Gladkova N, Kiseleva E, Streltsova O, Prodanets N, Snopova L, Karabut M, et al. Combined use of fluorescence cystoscopy and cross-polarization OCT for diagnosis of bladder cancer and correlation with immunohistochemical markers. J Biophotonics. 2013;6(9):687–98.PubMedCrossRefGoogle Scholar
  33. 33.
    Rao AR, Hanchanale V, Javle P, Karim O, Motiwala H. Spectroscopic view of life and work of the Nobel Laureate Sir C.V. Raman. J Endourol Endourol Soc. 2007;21(1):8–11.CrossRefGoogle Scholar
  34. 34.•
    Draga ROP, Grimbergen MCM, Vijverberg PLM, van Swol CFP, Jonges TGN, Kummer JA, et al. In vivo bladder cancer diagnosis by high-volume Raman spectroscopy. Anal Chem. 2010;82(14):5993–9. This study showed the feasibility of in vivo RS for diagnosis of bladder cancer using a Raman probe. Bladder cancer and normal urothelium had characteristic Raman spectra that were used to discriminate healthy and cancerous bladder tissue.PubMedCrossRefGoogle Scholar
  35. 35.
    de Jong BWD, Bakker Schut TC, Wolffenbuttel KP, Nijman JM, Kok DJ, Puppels GJ. Identification of bladder wall layers by Raman spectroscopy. J Urol. 2002;168(4 Pt 2):1771–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Crow P, Uff JS, Farmer JA, Wright MP, Stone N. The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro. BJU Int. 2004;93(9):1232–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Grimbergen MCM, van Swol CFP, Draga ROP, van Diest P, Verdaasdonk RM, Stone N, et al. Bladder cancer diagnosis during cystoscopy using Raman spectroscopy. Proc SPIE. 2009;7161:716114–716114–6.Google Scholar
  38. 38.
    Magee ND, Villaumie JS, Marple ET, Ennis M, Elborn JS, McGarvey JJ. Ex vivo diagnosis of lung cancer using a Raman miniprobe. J Phys Chem B. 2009;113(23):8137–41.PubMedGoogle Scholar
  39. 39.
    Zavaleta CL, Garai E, Liu JTC, Sensarn S, Mandella MJ, Van de Sompel D, et al. A Raman-based endoscopic strategy for multiplexed molecular imaging. Proc Natl Acad Sci U S A. 2013;110(25):E2288–97.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Vendrell M, Maiti KK, Dhaliwal K, Chang Y-T. Surface-enhanced Raman scattering in cancer detection and imaging. Trends Biotechnol. 2013;31(4):249–57.PubMedCrossRefGoogle Scholar
  41. 41.•
    Schäfauer C, Ettori D, Rouprêt M, Phé V, Tualle J-M, Tinet E, et al. Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. J Urol. 2013;190(1):271–7. This feasibility study demonstrated that bladder cancer could be detected using ultraviolet laser-induced autofluorescence measurements (AM). Converting the AMs into color-coded images, red indicating tumor and green indicating normal tissue, facilitated interpretation.PubMedCrossRefGoogle Scholar
  42. 42.
    Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. 2003;21(11):1369–77.PubMedCrossRefGoogle Scholar
  43. 43.
    Jain M, Robinson BD, Scherr DS, Sterling J, Lee M-M, Wysock J, et al. Multiphoton microscopy in the evaluation of human bladder biopsies. Arch Pathol Lab Med. 2012;136(5):517–26.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Yadav R, Mudalair K, Srivastava A, Rubin MA. Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery. BJU Int. 2012;108(9):1421–9.Google Scholar
  45. 45.
    Xu C. Multiphoton imaging for deep tissue penetration and clinical endoscopy. Proc SPIE. 2011;7891:78910H–78910H–4.Google Scholar
  46. 46.
    Rivera DR, Brown CM, Ouzounov DG, Pavlova I, Kobat D, Webb WW, et al. Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue. PNAS. 2011;108(43):17598–603.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Seibel EJ, Brentnall TA, Dominitz JA. New endoscopic and cytologic tools for cancer surveillance in the digestive tract. Gastrointest Endosc Clin N Am. 2009;19(2):299–307.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Seibel EJ, Brown CM, Dominitz JA, Kimmey MB. Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies. Gastrointest Endosc Clin N Am. 2008;18(3):467–78. viii.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Yoon WJ, Park S, Reinhall PG, Seibel EJ. Development of an automated steering mechanism for bladder urothelium surveillance. J Med Devices. 2009;3(1):011004.CrossRefGoogle Scholar
  50. 50.
    Soper TD, Porter MP, Seibel EJ. Surface mosaics of the bladder reconstructed from endoscopic video for automated surveillance. IEEE Trans Biomed Eng. 2012;59(6):1670–80.PubMedCrossRefGoogle Scholar
  51. 51.•
    Soper TD, Chandler JE, Porter MP, Seibel EJ. Constructing spherical panoramas of a bladder phantom from endoscopic video using bundle adjustment. 2011;7964:796417–796417–12, Mar. This study shows that stitching software is able to create a complete 360° panoramic image of a bladder phantom from video frames obtained with an SFE endoscope. Google Scholar
  52. 52.•
    Goldman RE, Bajo A, MacLachlan LS, Pickens R, Herrell SD, Simaan N. Design and performance evaluation of a minimally invasive telerobotic platform for transurethral surveillance and intervention. IEEE Trans Biomed Eng. 2013;60(4):918–25. This study demonstrates the design and evaluation of a prototype telerobotic system that provides a dexterous manipulator with access channels for the deployment of multiple tools, and is compatible with current resectoscope sheaths.PubMedCrossRefGoogle Scholar
  53. 53.
    Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. PharmacoEconomics. 2003;21(18):1315–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of UrologyStanford University School of MedicineStanfordUSA
  2. 2.Veterans Affairs Palo Alto Health Care SystemPalo AltoUSA

Personalised recommendations